Abstract:Human mesenchymal stem cells (hMSCs) could be well isolated and expanded from bone marrow and have been widely studied. In addition to hMSCs have ability to support hematopoiesis, they have generated a great deal of excitement as a potential source of cells for regenerative medicine and tissue engineering owing to their dramatic potential of proliferation and differentiation. However, the precise identity of hMSCs remains a challenge and the homogeneity of hMSCs is still controversial due in part to the lack of useful cell-specific markers. Thus, the objective of our study was to development monoclonal antibodies (MAbs) reactive with hMSCs surface antigens. hMSCs were isolated from bone marrow of volunteers on a density gradient solution by Ficoll-paque and cultured (LG-DMEM, 10%FBS) with their characteristic of adherence. hMSCs phenotype were analyzed by flow cytometry and demonstrated that they were uniformly positive for CD29, CD44, CD166 and CD105, negative for CD34, CD45 and HLA-DR. All hMSCs could be successfully induced to differentiate into osteogenic precursor cells, adipocytes and neuron cells when treated by correctly conditioned medium. There were detected to be no significant differences of phenotypes, growth characteristics and the potential of differentiation after either passage or programmed cryopreservation. Cultured and passaged hMSCs were used to immunized BALB/C mice at 1-week interval for 4 times, and their splenocytes subsequently harvested were fused with mouse SP 2/0 myeloma cells in the presence of PEG followed by culturing in the HAT selective medium. Indirect immunofluorescence assay (fluorescent antibody reacted with IgG and IgM isotypes) was utilized to preliminary screen the hybridoma colonies which synthesized and secreted antibodies having the specificity for cultured hMSCs. Out of 1248 wells initially plated, only 27 wells were tested positive for reactivity with living cultured hMSCs, and finally we got 5 hybridoma cell lines which could secreted MAbs steadily, named ZUB1, ZUB4, ZUC3, ZUE12, ZUF10. In order to identify hybridomas which secreted antibodies were only specific for hMSCs, peripheral blood cells, human malignant hematopoietic cell lines and rat marrow-derived mesenchymal stem cells were detected by indirect immunofluorescence analysis and subsequently a series of mesenchymal and non-mesenchymal derived tissues of human were performed by immunohistochemistry staining. The results demonstrated that all these 5 MAbs were specific for hMSCs except that ZUC3 had cross reaction with rat marrow-derived mesenchymal stem cells, and there were a few positive cells in the bone marrow. The subtype of monoclonal antibody ZUC3 was IgM, while other four MAbs were IgG1 and light chains of all MAbs were kappa. Using hybridoma cell lines, large amount of MAbs in ascites were generated then purified. MAbs ZUB1, ZUB4, ZUC3, ZUE12, ZUF10 were used to detected cultured hMSCs by flow cytometry, and percentage of positive cells are 87.39%, 88.07%, 88.12%, 69.89%, 83.67%, respectively. In conclusion, there 5 new MAbs that developed reactived with hMSCs surface antigens. Our study would further the understanding of hMSCs biological characterization and have potential application of new MAbs for identifying, sorting hMSCs derived from bone marrow. Further studies will focus on the characterization and epitopes of the MAbs to hMSCs.

Production of specific morphine antigen and the monoclonal antibodies

The Synthesis Of N-Morphine Hapten And Production Of Monoclonal Antibody

Microsoft Word-Yuan et al PDF

Generation and Characterization of Four Novel Monoclonal Antibodies Against Human Programmed Death-1 Molecule.

New Monoclonal Antibodies Reactive with Human Bone Marrow-Derived Mesenchymal Stem Cells.

Production and Application of Monoclonal Antibodies to GST

[Preparation of Monoclonal Antibodies Against Human Mesenchymal Stem Cells].

Production of Polyclonal Antibody of Morphine and Determination of Morphine in Urine by Capillary Electrophoresis Immunoassay with Laser-induced Fluorescence Detection

Design and Synthesis of a Bivalent Ligand to Explore the Putative Heterodimerization of the Mu Opioid Receptor and the Chemokine Receptor CCR5.

Production of Antitumor Human Monoclonal Antibodies by Human-Human or Mouse-Human Hybridoma

Epitope-directed monoclonal antibody production using a mixed antigen cocktail facilitates antibody characterization and validation

Electrochemical Studies on the Interaction of Morphine and Its Analogs with Its Antibody

Design and Synthesis of a Bivalent Probe Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Heterodimer

Preliminary Study on the Leukemia Targeting by a CD19 Antibody Conjugated with Saline Extracts from Mylabris Phalerata Pallas.

Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8b.

Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry.

Production of monoclonal antibodies against GPCR using cell-free synthesized GPCR antigen and biotinylated liposome-based interaction assay

Expression,purification and preparation of monoclonal antibody of HCA518 protein

Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosis

Production of Anti-Tumor Human Monoclonal Antibodies Using Different Approaches.

A morphine/heroin vaccine with new hapten design attenuates behavioral effects in rats.